Richard Eisenstadt

Richard Eisenstadt

No open positions remaining
68 year
Health Technology
Consumer Services
Commercial Services

Profile

Richard I.
Eisenstadt
's former job positions include Director-Strategic Planning & Development at Nimbus CD International, Inc., Finance Director at Cogent Neuroscience, Inc., Chief Financial Officer & Director at Neostx, Inc., Chief Financial Officer, Secretary & VP at OCERA Therapeutics LLC from 2003 to 2012, Chief Financial Officer & Secretary at Neos Therapeutics, Inc. from 2014 to 2021, Chief Financial Officer at ArborGen, Inc. in 2013, Chief Financial Officer & Vice President-Finance at Tranzyme, Inc. from 2003 to 2012, Chief Financial Officer & Vice President-Finance at Tranzyme Pharma, Inc. (Canada) from 2003 to 2012, Chief Financial Officer, Secretary & Treasurer at Aytu Biopharma, Inc. in 2021, and Chief Financial & Accounting Officer, Secretary at Altimmune, Inc. from 2021 to 2024.
Education: Mr. Eisenstadt holds an MBA from James Madison University and an undergraduate degree from The University of North Carolina at Charlotte.

Former positions of Richard Eisenstadt

CompaniesPositionEnd
Director of Finance/CFO 27/06/2024
ALTIMMUNE, INC. Director of Finance/CFO 27/06/2024
AYTU BIOPHARMA, INC. Director of Finance/CFO 30/12/2021
NEOS THERAPEUTICS, INC. Director of Finance/CFO 19/03/2021
Director of Finance/CFO 01/05/2014
See the detail of Richard Eisenstadt's experience

Training of Richard Eisenstadt

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

29

1st degree connections

12

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies12

Consumer Services

Commercial Services

Health Technology

Consumer Services

Health Technology

Non-Energy Minerals

Health Technology

Tranzyme Pharma, Inc. (Canada)

Consumer Services

Cogent Neuroscience, Inc.

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Richard Eisenstadt
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!